Entity

Time filter

Source Type

Cambridge, MA, United States

Patent
Constellation Pharmaceuticals | Date: 2014-03-14

The present invention relates to fusion proteins comprising at least one chromatin binding module and at least one reporter module, wherein a plurality of fusion proteins are capable of forming foci, and associated methods for identifying bromodomain inhibiting compounds.


Patent
Constellation Pharmaceuticals | Date: 2014-03-13

The present invention relates to compounds useful as inhibitors of one or more histone demethylses. The invention also provides pharmaceutically acceptable compositions comprising compounds of the present invention and methods of using said compositions in the treatment of various disorders.


Patent
Constellation Pharmaceuticals | Date: 2015-05-08

Agents for modulating methyl modifying enzymes, compositions and uses thereof are provided herein.


Patent
Genentech and Constellation Pharmaceuticals | Date: 2014-09-04

The present invention relates to compounds formula (I): and to salts thereof, wherein R


Patent
Constellation Pharmaceuticals | Date: 2015-03-18

Agents for modulating methyl modifying enzymes, compositions and uses thereof are provided herein.

Discover hidden collaborations